Studies have previously shown that epigenetic silencing of ID4 due to promoter hypermethylation appears to be the key mechanism in many cancers including prostate (Carey et al., 2009; Chinaranagari et al., 2014; Sharma et al., 2012). This evidence concerns the gene ID4 and cancer.